Cargando…
A Histologically Complete Response to Immunotherapy Using Pembrolizumab in a Patient with Giant Cell Carcinoma of the Lung: An Additional Report and Literature Review
We previously reported a case of giant cell carcinoma in the lung, in which the use of antiprogrammed death 1 (PD-1) immunotherapy resulted in substantial tumor reduction. In the present study, we describe an additional clinical course. A 69-year-old woman was diagnosed with giant cell carcinoma of...
Autores principales: | Kakimoto, Tomoo, Sasaki, Mamoru, Yamamoto, Tatsuya, Iwamaru, Arifumi, Ogata, Kentaro, Lee, Ko, Nakayama, Shingo, Minematsu, Naoto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815550/ https://www.ncbi.nlm.nih.gov/pubmed/31737389 http://dx.doi.org/10.1155/2019/1763625 |
Ejemplares similares
-
Pulmonary sclerosing pneumocytoma demonstrating intratumoral hematoma
por: Lee, Ko, et al.
Publicado: (2019) -
Pneumothorax as a rare presentation of bronchial schwannoma
por: Shimada, Takashi, et al.
Publicado: (2022) -
Nonsmall Cell Lung Carcinoma with Giant Cell Features Expressing Programmed Death-Ligand 1: A Report of a Patient Successfully Treated with Pembrolizumab
por: Nakayama, Shingo, et al.
Publicado: (2018) -
Asymptomatic Pulmonary Artery Intimal Sarcoma with Chest Wall Metastasis as an Initial Manifestation: An Autopsy Case
por: Kakimoto, Tomoo, et al.
Publicado: (2018) -
Pulmonary Mycobacterium kyorinense infection secondary to cavitary pulmonary tuberculosis
por: Nagao, Genta, et al.
Publicado: (2022)